EB2 pS222 antibody

Por um escritor misterioso

Descrição

EB2 S222 site is a target for phosphorylation by the CDKL5 protein kinase; loss-of-function mutations in the human CDKL5 gene are associated with CDKL5 Deficiency Disorder, a neurodevelopmental disorder with intractable epilepsy (Baltussen, Negraes, et al
EB2 pS222 antibody
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology
EB2 pS222 antibody
Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics. - Abstract - Europe PMC
EB2 pS222 antibody
Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics. - Abstract - Europe PMC
EB2 pS222 antibody
PDF) Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective
EB2 pS222 antibody
Antibody Search Engine - Enzo Life Sciences
EB2 pS222 antibody
Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics. - Abstract - Europe PMC
EB2 pS222 antibody
Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective
EB2 pS222 antibody
Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125, Microbial Cell Factories
EB2 pS222 antibody
Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability
EB2 pS222 antibody
Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125, Microbial Cell Factories
de por adulto (o preço varia de acordo com o tamanho do grupo)